Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech ...

Marvai LifeSciences has acquired assets and intellectual property from Molecular Assemblies at undisclosed terms. Marvai, a San Diego company, said Tuesday that the acquisition would expand the ...

“Molecular Assemblies is the original leader in enzymatic oligo synthesis, with strong foundational IP. Their team has made great strides in designing and developing an enzymatic DNA synthesis ...

Molecular Assemblies proprietary Fully Enzymatic SynthesisTM technology to enhance mRNA and oligonucleotide manufacturing capabilities within the TriLink BioTechnologies business “Molecular ...

Advance quantum information systems through innovative material design. Develop ultrasensitive biosensors for non-invasive ...

Maravai LifeSciences (MRVI) announced its acquisition of intellectual property and relevant assets from Molecular Assemblies, or MAI. The ...

“This is a very exciting, highly rigorous piece of work that gives new insights into this molecular-scale control of self-assembly. This helps the whole field move forward by building our ...

Some of the body's cells stay put for life, while others are free to roam. To move, these migratory cells rely on ...

SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property ...

Quantum researchers have long believed that strong spin interactions in qubits required covalent bonds, making large-scale ...